Advanced search
Publication Cover
Acta Oncologica Volume 29, 1990 - Issue 3
Journal homepage
302
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Anthracycline Pharmacokinetics: Limited sampling model for plasma level monitoring with special reference to epirubicin (Farmorubicin)

S. Eksborg Karolinska Pharmacy, Stockholm, Sweden
Pages 339-342 | Accepted 06 Jan 1990, Published online: 08 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Carina Ritzmo, Stefan Söderhäll, Jonas Karlén, Helen Nygren & Staffan Eksborg. (2007) PHARMACOKINETICS OF DOXORUBICIN AND ETOPOSIDE IN A MORBIDLY OBESE PEDIATRIC PATIENT. Pediatric Hematology and Oncology 24:6, pages 437-445.
Read now
H. T. Mouridsen, C. Alfthan, L. Bastholt, J. Bergh, M. Dalmark, S. Eksborg, S. Hellsten, M. Kjaer, C. Peterson, T. Skovsgård, J. B. Sørensen, C. Tropé & K. Aabo. (1990) Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid Tumours. Acta Oncologica 29:3, pages 257-285.
Read now

Articles from other publishers (14)

Sant P. Chawla, Sanjay Goel, Warren Chow, Fadi Braiteh, Arun S. Singh, Juneko E. Grilley Olson, Atsushi Osada, Iulian Bobe & Richard F. Riedel. (2020) A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma. Clinical Cancer Research 26:16, pages 4225-4232.
Crossref
Kjeld Schmiegelow & Inge van der Sluis. 2017. Childhood Acute Lymphoblastic Leukemia. Childhood Acute Lymphoblastic Leukemia 99 138 .
S.A. Kaestner & G.J. Sewell. (2007) Chemotherapy Dosing Part II: Alternative Approaches and Future Prospects. Clinical Oncology 19:2, pages 99-107.
Crossref
Josefine Palle, Britt-Marie Frost, Curt Peterson, Göran Gustafsson, Marit Hellebostad, Jukka Kanerva & Kjeld Schmiegelow. (2006) Doxorubicin pharmacokinetics is correlated to the effect of induction therapy in children with acute myeloid leukemia. Anti-Cancer Drugs 17:4, pages 385-392.
Crossref
Hans Ehrsson, Staffan Eksborg & Jonas Bergh. 2004. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 81 90 .
B.‐M. Frost, S. Eksborg, O. Björk, J. Abrahamsson, M. Behrendtz, A. Castor, E. Forestier & G. Lönnerholm. (2002) Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative study. Medical and Pediatric Oncology 38:5, pages 329-337.
Crossref
Carina Palm, Olle Bj?rk, Magnus Bj?rkholm & Staffan Eksborg. (2001) Quantification of doxorubicin in plasma?a comparative study of capillary and venous blood sampling. Anti-Cancer Drugs 12:10, pages 859-864.
Crossref
K. Sundby Hall, T. Wiklund, B. Erikstein, H. Holte, G. Kvalheim, H. Heen Sommer, A. Andersen, E. Skovlund, J. Bergh & C. Hall. (2001) Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients. Breast Cancer Research and Treatment 67:3, pages 235-244.
Crossref
N. Laubrock, G. Hempel, P. Schulze-Westhoff, G. Würthwein, S. Flege & J. Boos. (2000) The stability of doxorubicin and ldarubicin in plasma and whole blood. Chromatographia 52:1-2, pages 9-13.
Crossref
Staffan Eksborg, Carina Palm & Olle Bj?rk. (2000) A comparative pharmacokinetic study of doxorubicin and 4?-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure. Anti-Cancer Drugs 11:2, pages 129-136.
Crossref
J.-B. Holz, H. K?ppler, L. Schmidt, H.-W. Fritsch, K.-H. Pfl?ger & H. Jungclas. (1995) Limited sampling models for reliable estimation of etoposide area under the curve. European Journal of Cancer 31:11, pages 1794-1798.
Crossref
L. J. C. van Warmerdam, W. W. ten Bokkel Huinink, R. A. A. Maes & J. H. Beijnen. (1994) Limited-sampling models for anticancer agents. Journal of Cancer Research and Clinical Oncology 120:7, pages 427-433.
Crossref
B. Desoize & J. Robert. (1994) Individual dose adaptation of anticancer drugs. European Journal of Cancer 30:6, pages 844-851.
Crossref
Staffan Eksborg, Lennart Hardell, Nils-Olof Bengtsson, Marie Sjödin & Birgitta Elfsson. (1992) Epirubicin as a single agent therapy for the treatment of breast cancer — A pharmacokinetic and clinical study. Medical Oncology and Tumor Pharmacotherapy 9:2, pages 75-80.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.